ISRCTN39772441已完成未知
Randomised placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour - clinical trial with analyses of efficacy, cost effectiveness and acceptability
Greater Glasgow Health Board (North Glasgow University Hospitals Division) and The University of Glasgow (UK)0 个研究点目标入组 300 人开始时间: 2005年7月25日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 300
研究概览
简要总结
- 2006 results in http://www.ncbi.nlm.nih.gov/pubmed/16869966 2. 2009 results in http://www.ncbi.nlm.nih.gov/pubmed/19624440
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Female
入选标准
- •1. Bishop score less than or equal to 6
- •2. Singleton pregnancy
- •3. Nulliparity
- •4. Gestation greater than or equal to 37 completed weeks
- •5. Willing to self administer vaginal tablets
排除标准
- •Fetal compromise of sufficient severity such that daily fetal monitoring is scheduled
研究者
相似试验
已完成
1 期
Randomised, Double-blinded, Placebo-controlled Clinical Trial of Pandemic Influenza Inactive Vaccine on Healthy SubjectsISRCTN53344556Sinovac Biotech Co. Ltd (China)120
已完成
不适用
The effect of lanreotide on non-functioning pituitary macroadenoma sizepituitary adenomahypofyse adenoomNL-OMON27861Prof. dr. E. Fliers, Academic Medical Center, University of Amsterdam44
已完成
3 期
A phase III randomised, double blind, placebo controlled trial of carboplatin/etoposide with or without thalidomide in small cell lung cancerSmall cell lung cancerMalignant neoplasm of bronchus or lungCancerISRCTN16174527Sponsor not defined - Record supplied by London Lung Cancer Group724
已完成
不适用
A randomised, double blind, placebo-controlled study of the effects of Dehydroepiandrosterone (DHEA) replacement on vascular function in patients with primary and secondary adrenal insufficiencyISRCTN46268487Cardiff University (UK)40
已完成
不适用
A randomised prospective double-blind, placebo controlled trial of prophylactic oral levofloxacin following chemotherapy for lymphoma and solid tumoursBreast, testis, lung (small cell), lymphoma (Hodgkins), lymphoma (non-Hodgkins)Complications of procedures, not elsewhere classifiedCancerISRCTN49693355Cancer Research UK (CRUK) (UK)1,500
